Bogdan M Musielak (Bogdan Musielak)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Molecules (Basel, Switzerland)

ACS medicinal chemistry letters

Journal of medicinal chemistry

ChemMedChem

Jagiellonian University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jagiellonian University Oct 01 2013

Poland

PhD :: Faculty of Chemistry

Publications

Aleksandra Hec-Gałązka, Urszula Tyrcha, Jan Barczyński, Przemyslaw Bielski, Michał Mikitiuk, Ganna P Gudz, Radoslaw Kitel, Bogdan M Musielak, Jacek Plewka, Tomasz Sitar, Tad A Holak
Nonsymmetrically Substituted 1,1'-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction. ACS medicinal chemistry letters 15 (6) (2024)
Joanna Klimek, Oskar Kruc, Joanna Ceklarz, Beata Kaminska, Bogdan M Musielak, Robin van der Straat, Alexander S S Dömling, Tad A Holak, Damian Muszak, Justyna Kalinowska-Tluscik, Łukasz Skalniak, Ewa Surmiak
C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction. Molecules (Basel, Switzerland) 29 (11) (2024)
Joanna Klimek, Oskar Kruc, Joanna Ceklarz, Beata Kaminska, Bogdan M Musielak, Robin van der Straat, Alexander S S Dömling, Tad A Holak, Damian Muszak, Justyna Kalinowska-Tluscik, Łukasz Skalniak, Ewa Surmiak
C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction. Molecules (Basel, Switzerland) 29 (11) (2024)
Joanna Klimek, Oskar Kruc, Joanna Ceklarz, Beata Kaminska, Bogdan M Musielak, Robin van der Straat, Alexander S S Dömling, Tad A Holak, Damian Muszak, Justyna Kalinowska-Tluscik, Łukasz Skalniak, Ewa Surmiak
C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction. Molecules (Basel, Switzerland) 29 (11) (2024)
Aleksandra Hec-Gałązka, Urszula Tyrcha, Jan Barczyński, Przemyslaw Bielski, Michał Mikitiuk, Ganna P Gudz, Radoslaw Kitel, Bogdan M Musielak, Jacek Plewka, Tomasz Sitar, Tad A Holak
Nonsymmetrically Substituted 1,1'-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction. ACS medicinal chemistry letters 15 (6) (2024)
Ewa Surmiak, Julia Ząber, Jacek Plewka, Grzegorz Wojtanowicz, Justyna Kocik-Krol, Oskar Kruc, Damian Muszak, Ismael Rodriguez, Bogdan M Musielak, Monica Viviano, Sabrina Castellano, Łukasz Skalniak, Katarzyna Magiera-Mularz, Tad A Holak, Justyna Kalinowska-Tłuścik
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m -Terphenyl Derivatives. ACS medicinal chemistry letters 15 (1) (2023)
Ewa Surmiak, Julia Ząber, Jacek Plewka, Grzegorz Wojtanowicz, Justyna Kocik-Krol, Oskar Kruc, Damian Muszak, Ismael Rodriguez, Bogdan M Musielak, Monica Viviano, Sabrina Castellano, Łukasz Skalniak, Katarzyna Magiera-Mularz, Tad A Holak, Justyna Kalinowska-Tłuścik
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m -Terphenyl Derivatives. ACS medicinal chemistry letters 15 (1) (2023)
Hua Zhang, Shijia Zhou, Jacek Plewka, Caiyun Wu, Mengyu Zhu, Qimeng Yu, Bogdan M Musielak, Xiao Wang, Annoor Awadasseid, Katarzyna Magiera-Mularz, Yanling Wu, Wen Zhang
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2'-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors. Journal of medicinal chemistry (2023)
Radoslaw Kitel, Ewa Surmiak, Jan Borggräfe, Justyna Kalinowska-Tluscik, Przemyslaw Golik, Miroslawa Czub, Wiktor Uzar, Bogdan M Musielak, Mariusz Madej, Grzegorz M Popowicz, Grzegorz Dubin, Tad A Holak
Discovery of Inhibitory Fragments That Selectively Target Spire2-FMN2 Interaction. Journal of medicinal chemistry (2023)
Radoslaw Kitel, Ismael Rodriguez, Xabier Del Corte, Jack Atmaj, Magdalena Żarnik, Ewa Surmiak, Damian Muszak, Katarzyna Magiera-Mularz, Grzegorz M Popowicz, Tad A Holak, Bogdan M Musielak
Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments. ACS chemical biology 17 (9) (2022)
Agnieszka Kania, Waldemar Tejchman, Anna M Pawlak, Krystian Mokrzyński, Bartosz Różanowski, Bogdan M Musielak, Magdalena Greczek-Stachura
Preliminary Studies of Antimicrobial Activity of New Synthesized Hybrids of 2-Thiohydantoin and 2-Quinolone Derivatives Activated with Blue Light. Molecules (Basel, Switzerland) 27 (3) (2022)
Bartłomiej Bazan, Aleksandra Pałasz, Łukasz Skalniak, Dariusz Cież, Szymon Buda, Katarzyna Jędrzejowska, Sonia Głomb, Daniel Kamzol, Kinga Czarnota, Krystian Latos, Krzysztof Kozieł, Bogdan M Musielak
Application of bioorthogonal hetero-Diels-Alder cycloaddition of 5-arylidene derivatives of 1,3-dimethylbarbituric acid and vinyl thioether for imaging inside living cells. Organic & biomolecular chemistry 19 (27) (2021)
Edyta Zyla, Bogdan M Musielak, Tad A Holak, Grzegorz Dubin
Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis. Molecules (Basel, Switzerland) 26 (16) (2021)
Damian Muszak, Ewa Surmiak, Jacek Plewka, Katarzyna Magiera-Mularz, Justyna Kocik-Krol, Bogdan M Musielak, Dominik Sala, Radoslaw Kitel, Malgorzata Stec, Kazimierz Weglarczyk, Maciej Siedlar, Alexander S S Dömling, Łukasz Skalniak, Tad A Holak
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction. Journal of medicinal chemistry 64 (15) (2021)
Roberto Butera, Marta Ważyńska, Katarzyna Magiera-Mularz, Jacek Plewka, Bogdan M Musielak, Ewa Surmiak, Dominik Sala, Radoslaw Kitel, Marco de Bruyn, Hans W Nijman, Philip H Elsinga, Tad A Holak, Alexander S S Dömling
Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. ACS medicinal chemistry letters 12 (5) (2021)
Ewa Surmiak, Katarzyna Magiera-Mularz, Bogdan M Musielak, Damian Muszak, Justyna Kocik-Krol, Radoslaw Kitel, Jacek Plewka, Tad A Holak, Łukasz Skalniak
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action. International journal of molecular sciences 22 (21) (2021)
Magdalena Konieczny, Bogdan M Musielak, Justyna Kocik-Krol, Łukasz Skalniak, Dominik Sala, Miroslawa Czub, Katarzyna Magiera-Mularz, Ismael Rodriguez, Maja Myrcha, Malgorzata Stec, Maciej Siedlar, Tad A Holak, Jacek Plewka
Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint. Journal of medicinal chemistry 63 (19) (2020)
Bogdan M Musielak, Weronika Janczyk, Ismael Rodriguez, Jacek Plewka, Dominik Sala, Katarzyna Magiera-Mularz, Tad A Holak
Competition NMR for Detection of Hit/Lead Inhibitors of Protein-Protein Interactions. Molecules (Basel, Switzerland) 25 (13) (2020)
Ramon van der Vlag, M Yagiz Unver, Tommaso Felicetti, Aleksandra Twarda-Clapa, Fatima Kassim, Cagdas Ermis, Constantinos G Neochoritis, Bogdan M Musielak, Beata Labuzek, Alexander S S Dömling, Tad A Holak, Anna Katharina Herta Hirsch
Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination. ChemMedChem 15 (4) (2019)
Bogdan M Musielak, Justyna Kocik-Krol, Łukasz Skalniak, Katarzyna Magiera-Mularz, Dominik Sala, Miroslawa Czub, Malgorzata Stec, Maciej Siedlar, Tad A Holak, Jacek Plewka
CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? Molecules (Basel, Switzerland) 24 (15) (2019)

Bogdan M Musielak.css-eqlu8i{font-size:small;padding-left:4px;} (Bogdan Musielak)

Publication Activity (10 Years)

Top Topics

Top Venues

Bogdan M Musielak (Bogdan Musielak)